25% of people are saying (in surveys conducted by the CFF) that they are skipping medications or delaying medications or skipping doctor appointments because of cost of care issues." She added that "one of the things that the Foundation has done," is to "develop resources that can help patients bridge that gap through patient access programs, and so forth." See also Cystic Fibrosis Foundation Telaprevir References External links Biotechnology companies of the United States Pharmaceutical companies of the United States Companies based in Boston Biotechnology companies established in 1989 Pharmaceutical companies established in 1989 Health care companies based in Massachusetts Companies listed on the Nasdaq Orphan drug companies Life sciences industry Biopharmaceutical companies